Cutera’s AviClearTM 12-Month Clinical Data Presented At 42nd Annual Fall Clinical Dermatology Conference

Cutera, Inc. (NASDAQ:CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that the 12-month clinical data related to AviClear, the first and only FDA-cleared energy-based device for the treatment of mild, moderate, and severe acne, was presented at the Annual Fall Clinical Dermatology Conference, which took place October 20-23 in Las Vegas, Nevada.